Search

everythinglearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.

Biotin and acetazolamide improved hair and nail growth, mental function, and reduced headaches in a child with autism.

Minoxidil decreases LH expression, while hydralazine has mixed effects on prolyl and lysyl hydroxylase activities.

Upadacitinib may effectively treat alopecia areata without side effects.

Alopecia areata may be linked to kidney issues, but more research is needed.

DMG-Na may help reduce hair loss and improve hair growth, but more research is needed.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

DDAIP-HCl significantly increases minoxidil absorption into the skin.

Immunoadsorption successfully treated a man's resistant polymyositis.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Apremilast did not work for treating severe alopecia areata.

New compounds show promise as nonsteroidal treatments for hair loss.

Microneedles with minoxidil and nitric oxide improve hair growth effectively and painlessly.

A new microneedle system effectively delivers a vasodilator to hair follicles, promoting hair growth better than current treatments.

Drugs that block GSK-3 show promise for treating various diseases.

A(1-7) treatment reduces symptoms of lupus in mice.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Hair loss patients may have different polyamine levels in various scalp areas.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.